Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : MRTX crawled time : 00:00 save search
Mirati Therapeutics Announces U.S. FDA Accelerated Approval of KRAZATI™ (adagrasib) as a Targeted Treatment Option for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) with a KRASG12C Mutation
Published: 2022-12-12 (Crawled : 00:00) - prnewswire.com
MRTX | $58.7 -0.17% 0.34% 0
|
Health Technology
|
| O: 1.16%
H: 1.41%
C: 0.19%
krasg12 treatment fda lung approval therapeutics cancer
Mirati Therapeutics Presents Late-Breaking Results Evaluating Concurrent Adagrasib and Pembrolizumab in First-Line Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
Published: 2022-12-05 (Crawled : 00:00) - prnewswire.com
MRTX | $58.7 -0.17% 0.34% 0
|
Health Technology
|
| O: -16.68%
H: 3.91%
C: -7.45%
lung therapeutics results cancer
Zai Lab Partner Mirati Therapeutics Presents Late-Breaking Results Evaluating Concurrent Adagrasib and Pembrolizumab in First-Line Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
Published: 2022-12-05 (Crawled : 00:00) - globenewswire.com
ZLAB | News | $14.2 3.5% 3.38% 690K
|
Health Technology
|
| O: 0.74%
H: 2.03%
C: 0.06%
MRTX | $58.7 -0.17% 0.34% 0
|
Health Technology
|
| O: -16.68%
H: 3.91%
C: -7.45%
lung therapeutics results cancer
Mirati Therapeutics To Present At Guggenheim Healthcare Talks 2021 Oncology Days
Published: 2021-02-04 (Crawled : 00:00) - biospace.com/
MRTX | $58.7 -0.17% 0.34% 0
|
Health Technology
|
| O: -0.37%
H: 3.64%
C: 1.95%
guggenheim healthcare
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.